Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies.

M, Hanefeld; M, Cagatay; T, Petrowitsch; D, Neuser; D, Petzinna; M, Rupp

doi:10.1016/s0195-668x(03)00468-8

Public

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies.

Shared by NobleBlocks on Jan 1, 2004 • 12:00 AM UTC

Authors:

Hanefeld M

Cagatay M

Petrowitsch T

Abstract

Aims To assess if treatment with the alpha-glucosidase inhibitor acarbose can reduce cardiovascular events in type 2 diabetic patients.Methods and results This meta-analysis included seven randomized, double-blind, placebo-controlled acarbose studies with a minimum treatment duration of 52 weeks. Ty...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!